Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-233284
Filing Date
2023-09-12
Accepted
2023-09-12 13:20:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d479763ddefa14a.htm DEFA14A 23234
  Complete submission text file 0001193125-23-233284.txt   24168
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

EIN.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37785 | Film No.: 231249562
SIC: 2834 Pharmaceutical Preparations